Literature DB >> 17401461

Gene expression profiling of chemically induced rat bladder tumors.

Ruisheng Yao1, Yijun Yi, Clinton J Grubbs, Ronald A Lubet, Ming You.   

Abstract

A variety of genetic alterations and gene expression changes are involved in the pathogenesis of bladder tumors. To explore expression changes in 4-hydroxybutyl(butyl)nitrosamine-induced rat bladder tumors, microarray analysis was performed. Analysis yielded 1,138 known genes and 867 expressed sequence tags that were changed when comparing tumors to normal rat epithelia. Altered genes included cell cycle-related genes, EGFR-Ras signaling genes, apoptosis genes, growth factors, and oncogenes. Using the pathway visualization tool GenMAPP, we found that these genes can be grouped along several pathways that control apoptosis, cell cycle, and integrin-mediated cell adhesion. When comparing current data with previous mouse bladder tumor data, we found that > 280 of the same known genes were differentially expressed in both mouse and rat bladder tumors, including cell cycle-related genes, small G proteins, apoptosis genes, oncogenes, tumor-suppressor genes, and growth factors. These results suggest that multiple pathways are involved in rat bladder tumorigenesis, and a common molecular mechanism was found in both rat and mouse bladder tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401461      PMCID: PMC1838579          DOI: 10.1593/neo.06814

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  64 in total

1.  Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.

Authors:  Dejun Shen; Farzad Nooraie; Yahya Elshimali; Victor Lonsberry; Jianbo He; Shikha Bose; David Chia; David Seligson; Helena R Chang; Lee Goodglick
Journal:  Hum Pathol       Date:  2006-08-10       Impact factor: 3.466

Review 2.  Linking Rap to cell adhesion.

Authors:  Johannes L Bos
Journal:  Curr Opin Cell Biol       Date:  2005-04       Impact factor: 8.382

3.  Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary results.

Authors:  Essam Elsamman; Tomoharu Fukumori; Ashraf A Ewis; Nermin Ali; Kazuaki Kajimoto; Yasuo Shinohara; Mitsuru Ishikawa; Masayuki Takahashi; Masa-Aki Nishitani; Yoshinobu Baba; Hiro-omi Kanayama
Journal:  Urol Oncol       Date:  2006 Mar-Apr       Impact factor: 3.498

4.  Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.

Authors:  Kim L Wang; Tsung-Teh Wu; Erika Resetkova; Huamin Wang; Arlene M Correa; Wayne L Hofstetter; Stephen G Swisher; Jaffer A Ajani; Asif Rashid; Stanley R Hamilton; Constance T Albarracin
Journal:  Clin Cancer Res       Date:  2006-08-01       Impact factor: 12.531

5.  Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma.

Authors:  C P Paweletz; D K Ornstein; M J Roth; V E Bichsel; J W Gillespie; V S Calvert; C D Vocke; S M Hewitt; P H Duray; J Herring; Q H Wang; N Hu; W M Linehan; P R Taylor; L A Liotta; M R Emmert-Buck; E F Petricoin
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

6.  Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.

Authors:  C J Grubbs; R A Lubet; A T Koki; K M Leahy; J L Masferrer; V E Steele; G J Kelloff; D L Hill; K Seibert
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

7.  A molecular signature in superficial bladder carcinoma predicts clinical outcome.

Authors:  Lars Dyrskjøt; Karsten Zieger; Mogens Kruhøffer; Thomas Thykjaer; Jens L Jensen; Hanne Primdahl; Natasha Aziz; Niels Marcussen; Klaus Møller; Torben F Orntoft
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

8.  The annexin protein lipocortin 1 regulates the MAPK/ERK pathway.

Authors:  L C Alldridge; H J Harris; R Plevin; R Hannon; C E Bryant
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

9.  Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.

Authors:  Kazumori Kawakami; Hideki Enokida; Tokushi Tachiwada; Takenari Gotanda; Kengo Tsuneyoshi; Hiroyuki Kubo; Kenryu Nishiyama; Masaki Takiguchi; Masayuki Nakagawa; Naohiko Seki
Journal:  Oncol Rep       Date:  2006-09       Impact factor: 3.906

10.  Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations.

Authors:  A Lamy; F Gobet; M Laurent; F Blanchard; C Varin; C Moulin; A Andreou; T Frebourg; C Pfister
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

View more
  12 in total

1.  Molecular credentialing of rodent bladder carcinogenesis models.

Authors:  Paul D Williams; Jae K Lee; Dan Theodorescu
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

2.  A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma.

Authors:  Carl-Jørgen Arum; Yosuke Kodama; Natale Rolim; Marius Widerøe; Endre Anderssen; Trond Viset; Marit Otterlei; Steinar Lundgren; Duan Chen; Chun-Mei Zhao
Journal:  World J Urol       Date:  2010-04-08       Impact factor: 4.226

3.  Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer.

Authors:  Carl-Jørgen Arum; Endre Anderssen; Trond Viset; Yosuke Kodama; Steinar Lundgren; Duan Chen; Chun-Mei Zhao
Journal:  Neoplasia       Date:  2010-06       Impact factor: 5.715

4.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

5.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

6.  Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Authors:  Suraj Konnath George; Veronica Tovar-Sepulveda; Steven S Shen; Weiguo Jian; Yiqun Zhang; Susan G Hilsenbeck; Seth P Lerner; Carolyn L Smith
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

7.  DNA repair gene polymorphisms may be associated with prognosis of upper urinary tract transitional cell carcinoma.

Authors:  Miwa Sasaki; Shigeru Sakano; Naoko Okayama; Jumpei Akao; Tomohiko Hara; Yoshihisa Kawai; Chietaka Ohmi; Yuji Hinoda; Katsusuke Naito
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

8.  Dysregulation of pathways involved in the processing of cancer and microenvironment information in MCA + TPA transformed C3H/10T1/2 cells.

Authors:  Shivam Priya; Akanksha Nigam; Preeti Bajpai; Sushil Kumar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-03-22       Impact factor: 2.416

9.  Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model.

Authors:  Seon-Kyu Kim; Seok-Joong Yun; Jiyeon Kim; Ok-Jun Lee; Suk-Chul Bae; Wun-Jae Kim
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

10.  Knockdown of Ki-67 by dicer-substrate small interfering RNA sensitizes bladder cancer cells to curcumin-induced tumor inhibition.

Authors:  Sivakamasundari Pichu; Swapna Krishnamoorthy; Andrei Shishkov; Bi Zhang; Peter McCue; Biddanda C Ponnappa
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.